Leveraging the EU Whistleblower Directive to Improve Employee Reporting (Part I of II)August 20, 2020
United States Files False Claims Act Complaint Against Drug Maker Teva Pharmaceuticals Alleging Illegal KickbacksAugust 20, 2020
Privilege Waived When Internal Investigation Provided to Outside PR Firm; United States District Court for the District of Massachusetts No. 15-11890-ADB, U.S., et al. ex rel. Lisa Wollman M.D. v. Massachusetts General Hospital Inc., et al.August 19, 2020
Government Liable to Contractor for Nearly $200,000 in Legal Fees Incurred While Defending Qui Tam ActionAugust 19, 2020
Raising the (c)(2)(A) Bar: Senior Senator Seeks to Require Department of Justice to Meet Higher Standard in Dismissing False Claims Act CasesAugust 19, 2020
Investigations in the Time of Coronavirus: Conducting FCPA Investigations during the PandemicAugust 18, 2020
Allegation That Defendants Billed for Procedures Never Conducted Not a ‘Difference of Medical Opinion’; United States District Court for the Middle District of Georgia, Athens Division, No. 3:19-CV-107 (CAR), U.S. v. Ellis Pain Center, et al.August 18, 2020
Recent DOJ Prosecution Declination Supports Its Promise Of Leniency For Self-Reporting Violations Even When “Bags of Money” Are InvolvedAugust 18, 2020
